Royalty Pharma plc
Marshall Urist (EVP, Research & Investments) reports RPRX insider transactions
AI-generated summary
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc Class A Ordinary Shares, received a grant of 5,341 shares on November 4, 2026, holding 5,341 shares directly afterwards. On November 6, 2026, the insider also reported 150,000 shares in conversion transactions indirectly through Sandy Lamm LLC, holding 150,000 shares indirectly afterwards.
Key facts
- Insider
- Marshall Urist · EVP, Research & Investments
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | A · grantFootnotes F1 | +5,341 | $0.00 | $0.00 | 5,341 | Direct |
| Nov 6, 2026 | C · conversionFootnotes F2 | +150,000 | $0.00 | $0.00 | 150,000 | Indirect (By Sandy Lamm LLC) |
| Nov 6, 2026 | C · conversionLP interests in RPI US Partners 2019, LPFootnotes F2, F3 | −15,000 | $0.00 | $0.00 | 229,412 | Indirect (By Sandy Lamm LLC) |
Footnotes
- F1 Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.
- F2 These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("RPH"). Each Class B Interest in RPH so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Amended and Restated Exchange Agreement. No additional value will be paid by the Reporting Person in connection with the exchange.
- F3 Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in RPH at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in RPH issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.
Remarks: In addition to the Class A Ordinary Shares and RPI US LP Interests disclosed above, the Reporting Person holds Class E Ordinary Shares of RPH exchangeable into 1,356,528 Class A Ordinary Shares. Class E Ordinary Shares of RPH are subject to vesting conditions.
More RPRX filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- SC 13G/A
Filed Nov 5, 2026
- 10-Q
Filed Nov 4, 2026
- 8-K
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.